Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion 
Embraer Boosts Aircraft Deliveries in Q4 2025, Signaling Strong Growth Into 2026 
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
Lenovo Unveils AI Cloud Gigafactory With NVIDIA and Launches New AI Platform at CES 2026 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
China Reviews Meta’s $2 Billion AI Deal With Manus Amid Technology Control Concerns 
AMD Unveils Next-Generation AI and PC Chips at CES, Highlights Major OpenAI Partnership 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
FDA Limits Regulation of Wearable Devices and Wellness Software, Boosting Health Tech Industry 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
SAN FRANCISCO, April 05, 2016 -- BioQ Pharma, a specialty pharmaceutical company focused on the development and commercialization of large volume ready-to-use infusible pharmaceuticals, announced today that the Company will be presenting at the 15th Annual Needham Healthcare Conference to be held in New York City on April 12th and 13th, 2016.
Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, April 13th at 8:40 a.m. Eastern Daylight Time.
About BioQ Pharma
BioQ Pharma is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, and West Pharmaceutical Services.
Company Contact Information: Josh Kriesel President and CEO 415-336-6496 Ron Pauli Chief Financial Officer 415-889-7707 Media: Stephanie Carrington Integrated Corporate Relations, Inc (ICR) 646-277-1282
